Evidence map›Paper›PMID 18505429›Full record

ArticleClinical and experimental immunology2008

Associations of MICB with cervical cancer in north-eastern Thais: identification of major histocompatibility complex class I chain-related gene B motifs influencing natural killer cell activation.

A Jumnainsong, P Jearanaikoon, S Khahmahpahte, W Wongsena, A V Romphruk, B Chumworathayi, K Vaeteewoottacharn, M Ponglikitmongkol, A Romphruk, C Leelayuwat

Open access · bronzeAbstract read
In one paragraph

Article in Clinical and experimental immunology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

A JumnainsongFaculty of Medical Technology, Mahidol University, Bangkok, Thailand.
P Jearanaikoon
S Khahmahpahte
W Wongsena
A V Romphruk
B Chumworathayi
K Vaeteewoottacharn
M Ponglikitmongkol
A Romphruk
C Leelayuwat
Mahidol University · THMedical Diagnostic Laboratories (United States) · USCentre for Research and Development · ZWKhon Kaen University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The expression of MICB, a member of the major histocompatibility complex class I chain-related gene B family, is induced in response to cellular stress. It is one of the ligands to the NKG2D receptor. MICB is polymorphic, but the distribution of MICB polymorphism in north-eastern Thais and their potential associations with cancer have not yet been elucidated. In this study, polymerase chain reaction-sequence-specific primers were developed to identify 15 MICB alleles and one group of alleles. We performed MICB typing in 100 healthy north-eastern Thai females (NETF) and 99 cervical cancer patients to evaluate the association of MICB polymorphisms and the risk of developing cervical cancer. Eight and nine alleles were detected in the NETF and cervical cancer respectively. MICB*00502 was associated negatively with a corrected P-value of 0.0009, suggesting the existence of a protective allele in cervical cancer. Amino acid substitutions carried by this allele were investigated for their potential involvement in natural killer (NK) cell activation. Although lysine at amino acid position 80 (Lys80) and aspartic acid at position 136 (Asp136) were associated negatively with cervical cancer, only MICB carrying Asp136 could induce NK cell killing more efficiently than MICB-Lys80 when the NK cells were blocked by anti-NKG2D. This result suggested that aspartic acid at position 136 may affect NKG2D binding, leading to different degrees of immune cell activation.

Indexed as

Genes, MHC Class IPolymorphism, GeneticAllelesAmino Acid SubstitutionAsian PeopleCase-Control StudiesCells, CulturedDNA PrimersFemaleGenetic Predisposition to DiseaseHaplotypesHistocompatibility Antigens Class IHumansKiller Cells, NaturalLymphocyte ActivationNK Cell Lectin-Like Receptor Subfamily KDNA PrimersHistocompatibility Antigens Class IKLRK1 protein, humanMICB antigenNK Cell Lectin-Like Receptor Subfamily KReceptors, ImmunologicReceptors, Natural Killer Cell

Identifiers

PMID18505429
PMCPMC2492893
OpenAlexW2085372282

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.